NRG/RTOG 1119, “Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination with Concurrent Lapatinib in Patients with Brain Metastasis From HER2-Positive Breast Cancer: A Collaborative Study of NRG Oncology and KROG,” is closed to accrual as of 5 PM ET Thursday, September 12, 2019, because it is has reached its accrual target, as broadcast on September 10.


Reminder: Data collection and site IRB renewal for closed studies must continue until the study is terminated.


Please distribute this information to the appropriate personnel at participating affiliate/NCORP component institutions.



This message was sent to by
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Unsubscribe from all mailings Unsubscribe | Manage Subscription | Forward Email | Report Abuse